IGF-I regulates cell growth, differentiation, and survival in many cultured nerve cell lines. The present study was undertaken in the human neuroblastoma cell line, SH-SY5Y, to elucidate whether there are differences in the IGF-dependent signal transduction pathways that stimulate proliferation compared to those that induce differentiation.
INSULIN-LIKE
growth factor-I (IGF-I) has a variety of bioactivities including induction of cell proliferation as well as differentiation in many cell types. In nerve cell lines, IGF-I has been reported to regulate cell proliferation, differentiation, and survival in vitro [1] . In addition, IGF-I is shown to be important for the development of the nerve system in vivo, as demonstrated by studies using IGF-I overexpressing transgenic mice and IGF-I knockout mice [2, 3] IGF-I signaling is mediated by several pathways, including the MAP kinase and phosphatidylinositol (PI) 3-kinase pathways. IGF-I binding to its cognate receptor, the type I IGF receptor (IGF-I receptor), results in receptor tyrosine kinase activation followed by phosphorylating intracellular proteins, such as Shc, insulin receptor substrate (IRS)-1 and IRS-2 [4] . Phosphorylated Shc and IRS by receptor kinase bind to . This complex stimulates the exchange GDP to GTP on p2lras. Activated p2lras then associates with Raf (MAP kinase kinase kinase) prior to its activation. Raf then activates MEK (MAP kinase kinase), which in turn activates extracellular signal-regulated protein (Erk; MAP kinase) [5, 6] . Activation of the MAP kinase pathway leads to the expression of the immediate early genes, such as c fos, c jun and c-myc and next they induce to express the late response genes [1] . As a result, various biological activities, including cell proliferation or cell differentiation, are induced. By contrast, phosphorylated IRS by receptor kinase also binds to the 85 kDa regulatory subunit of PI 3-kinase and activates the 110 kDa catalytic subunit of PI 3-kinase [7, 8] . Activated PI 3-kinase produces PI3P, which leads to activation of the downstream kinases, such as PKB/Akt and aPKC [9] . Activation of the PI 3-kinase pathway is also known to induce proliferation, differentiation, and survival [10, 11] .
SH-SY5Y is one of the several established human neuroblastoma cell lines. This line can be induced to differentiate further along a sympathetic neuronal lineage, providing model systems for study of mechanisms regulating neuronal development [12] [13] [14] . IGF-I and basic fibroblast growth factor (bFGF) stimulate the proliferation of this cell line [15] , and some growth factors, including IGF-I, can induce differentiation to a neuronal phenotype [16] [17] [18] . It has been shown that IGF-I acts through IGF-I receptor for its biological effects in SH-SY5Y cells, but it is unclear what signaling pathways stimulated by the type I IGF receptor lead to proliferation and/or differentiation. However, there are reports suggesting that the association of Shc with Grb2 is essential for IGF-I-mediated neurite outgrowth, and that an IRS-2-PI 3-kinase interaction may regulate growth cone extension and membrane ruffling [19] .
IGF-I is quite unique among the many growth factors, in that it is well known to induce both cell growth and differentiation of nerve cells. As we introduced here, it remains to be elucidated what signaling pathways among the classically described IGF-I signaling pathways, such as the MAP kinase and PI 3-kinase pathways, are required for each process. The present study was undertaken to elucidate whether there are differences in the IGF-dependent signal transduction pathways that induce cell growth and differentiation.
To this end we utilized the MEK inhibitor, PD98059, and the PI 3-kinase inhibitor, LY294002, in the human neuroblastoma cell line, SH-SY5Y.
We assessed cell growth by measuring
[3H]thymidine incorporation into DNA and cell number, while differentiation was assessed by measuring neurite outgrowth and mRNA levels of neuropeptide Y (NPY).
Materials

Materials and Methods
Recombinant human IGF-I (hIGF-I) was kindly donated by Dr. Toshiaki Okuma (Fujisawa Pharmaceutical Co., Osaka, Japan).
Leupeptin and pepstatin were generously gifted from Dr. Takaaki Aoyagi (Institute of Microbial Chemistry, Tokyo, Japan). Anti-phosphotyrosine monoclonal antibody was kindly provided by Dr. Takao Yamori (Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan). Anti-IGF-I receptor j3-subunit and Shc antibody were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, U.S.A.) and Upstate Biotechnology Inc. (Lake Placid, NY, U.S.A.), respectively. Polyclonal anti-IRS-1 antibody and anti-IRS-2 antibody were prepared by immunizing rabbits with synthetic peptides according to Ogihara et al. [20] . Anti-phospho-Erk polyclonal antibody (#91015) and anti-phospho-Akt polyclonal antibody (#92715) were obtained from New England Biolabs (Beverly, MA, U.S.A.).
[Methyl-3H] thymidine (6.5 mCi/mmol), and [a-32P] dCTP (3,000 Ci/mmol) were purchased from Amersham (Arlington Heights, IL, U.S.A.). Other chemicals were of the reagent grade available commercially.
Cell Cultures
The SH-SY5Y cells, a subclone of the human neuroblastoma cell line SK-N-SH, were kindly provided by Dr. Kimihiko Sano (School of Medicine, University of Kobe, Hyogo, Japan). Cells were cultured in RPMI1640 medium with 10% fetal calf serum (FCS, Nichirei Co., Tokyo), penicillin (100 U/ml), and streptomycin (50 tCg/ml) in 150 cm2 flasks with 5% CO2 at 37°C in humidified incubator according to Pahlman et al. [14J. The medium was replaced every 3 days and the cells were passed every 7 days before they reached confluence. Prior to each experiment, cells were basically passed at 1 x 104 cells /cm2 and cultured in the RPMI1640 medium with 10% FCS for 48 h. They were washed with Hanks' balanced salt solution (HBSS) and starved for 24 h to achieve quiescence under serum-free conditions, SHTE-medium (RPMI1640 medium containing 30 nM selenium, 10 nM hydrocortisone, 30 tcg/ml transferrin and 10 nM 13-estradiol, and the same antibiotics as described above). The cells were further incubated in the SHTE-medium containing various agents. In the case of inhibitor studies, cells were pretreated with various inhibitors 30 min before the addition of IGF-I.
Measurement of Thymidine Incorporation into DNA
Cells (2.0 x 104) were plated in 24 well plates and cultured as described above to achieve quiescence. They then were incubated with or without IGF-I for additional 24 h and labeled with [methyl-3H]thymidine for the last 4 h, and [3H]thymidine incorporation into DNA was measured as described previously [21] . In all experiments, each experimental point represents the mean of three replicate wells. treated with or without IGF-I for 4 days. Total RNA was prepared as described previously by Puissant and Houdebine [22] with a slight modification. The cells were harvested in 6 ml of a solution (solution D, containing 4 M guanidinium thiocyanate, 25 mM sodium citrate, pH 7.0, 0.5% sarcosyl and 0.1 M 2-mercaptoethanol).
To extract total RNA, 0.6 ml of 2 M sodium acetate, pH 4.0, 6 ml phenol (which had been saturated with water), 1.2 ml of chloroform-isoamylalcohol (49:1) were added and the mixture was shaken vigorously at each addition. The mixture was centrifuged at 10,000 x g for 10 min at 4°C. The water phase was saved and mixed with an equal volume of isopropanol. The mixture was kept at 4°C for more than 2 h, and the precipitated RNA was centrifuged at 3,000 x g for 10 min at 4°C and suspended in 0.6 ml 4 M lithium chloride. The suspension was pipetted repeatedly to extract polysaccharides, and then centrifuged at 3,000 x g for 10 min at -20°C.
The precipitate was redissolved in 0.4 ml of a solution containing 10 mM Tris-HCI, pH 7.5,1 mM EDTA, 0.5% SDS. This solution was mixed with 0.4 ml of chloroform-isoamylalcohol (49 :1) again and centrifuged at 3,000 x g for 10 min at 4°C. The water phase was mixed with 0.4 ml of isopropanol and 0.04 ml of 2 M sodium acetate, pH 5.0. The precipitated RNA in the mixture was recovered by centrifugation at 15,000 x g for 10 min at 4°C, washed with 0.3 ml of 70% ethanol, dried in vacuo, and dissolved in a solution containing 10 mM Tris-HCI, pH 7.5,1 mM EDTA. By determining the absorbance at 260 and 280 nm, the purity of RNA was confirmed and the concentration of RNA in the solution was calculated.
Quantification of Cell Numbers
Northern Blot Analysis
Cells were sparsely plated in 35 mm dishes and cultured as described above to achieve quiescence. Total RNA Preparation Cells (7.85 x 105) were plated in 100 mm dishes, and after culture as described above, they were Northern blot analysis was performed as described previously [23] with a slight modification. For each sample 15 pg of total RNA was dissolved in 20 tcl of a solution containing 50% deionized formamide, 3% formaldehyde, 40 tCg/ml of ethidium bromide and 1/10 volume of 10 x loading buffer containing 50% glycerol, 1 mM EDTA, pH 7.5, 0.4% bromophenol blue and 0.4% xylene cyanol in 3-(N-morpholino) propanesulphonic acid (MOPS) buffer solution and heated at 65°C for 15 min. The denatured RNA was electrophoresed on a 1.5% agarose and 3% formaldehyde gel. After electrophoresis, the amount of RNA in the gel was assessed with a transilluminator. The RNA in the gel was transferred to a nylon membrane (GeneScreen Plus, NENTM Life Science Products, Boston, MA, U.S.A.), and hybridized with cDNA probes for neuropeptide tyrosine (NPY) (Health Science Research. Resources Bank, Osaka, Japan) and glyceraldehyde-3-phosphatedehydrogenase (G3PDH) (Clontech, Palo Alto, CA, U.S.A.). The probes were labeled with [a-32P]dCTP (3,000 Ci/mmol; Amersham, Bucks, UK) using Amersham's multiprime DNA labeling systems according to the manufacturer's protocol. Each band was quantified by Bio-Imaging Analyzer System, Fujix Bas 2000 (Fuji Film Co., Tokyo, Japan).
Assessment of Neurite Outgrowth
For analysis of neurite outgrowth, the cells (0.9 x 105) were plated on 35 mm dishes and cultured as described above. Twenty-four hours after the addition of IGF-I, the number of neurite bearing cells among a total of three hundred cells was counted. Processes longer than the cell body were considered neurites. In all experiments, each experimental point represents the mean of three replicate dishes.
5-Bromo-2 deoxyuridine (Brd U) Assay
Cells (2.0 x 104) were plated in 24 well plates, cultured as described above, and treated with or without IGF-I for 4 days. BrdU was added 1 h before the termination of each experiment and BrdU assay was performed using In Situ Cell Proliferation Kit, AP (Boehringer Mannheim, Germany) according to the manufacturer's protocol. Cultures were photographed in a phase-contrast microscope (Olympus, Tokyo, Japan).
Immunoblot Analysis using Antiphosphotyrosine Antibody, Antiphospho-Erk Antibody or Antiphospho-Akt Antibody Cells (7.85 x 105) were plated on 100 mm dishes, cultured as described above, and treated with or without IGF-I for 1 min or for several other times. The cells were lysed at 0°C in 0.2 ml of a lysis buffer solution containing 20 mM Tris-HC1 pH 8.0, 150 mM NaCI, 1 mM NaF, 10% glycerol, 1 % NP-40, 1 mM Na3VO4, 100 KIU/ml aprotinin, 20 ; ig/ml phenylmethylsulphonyl fluoride (PMSF), 10 ig/ml leupeptin, 5 pg/ml pepstatin, 10 mg/ml p-nitrophenyl phosphate (PNPP).
The protein in each lysate was assayed according to the method of Bradford [24] . One hundred ,ccl of concentrated 3 x Laemmli's sample buffer solution containing 9% SDS and 6% 2-mercaptoethanol was added to the lysates and the mixture was incubated for 5 min at 100°C. These samples were then stored at -80°C until electrophoresis. For each sample adequate quantities of proteins were run on suitable percentage of SDS-PAGE using a Hoefer Standard Slab Gel Units 5E600 apparatus (Hoefer Scientific Instruments, San Francisco, CA, U.S.A.). The proteins on the gel were transferred to a nitrocellulose membrane and immunoblot analysis was performed as described previously [25] . For detection of each protein, membrane was incubated in the blocking buffer containing a monoclonal antiphosphotyrosine antibody (1: 3,000), anti-phosphoErk antibody (1:1,000) or anti-phospho-Akt antibody (1:1,000).
Immunoprecipitation
of IRSs or Shc, followed by Immunoblotting with Anti phosphotyrosine Antibody Cells (7.85 x 105) were plated on 100 mm dishes and cultured as described above until they became quiescent. The cells were treated with or without IGF-I for 1 min or several time points. The cells were then harvested at 0°C in 400 tcl of immunoprecipitation buffer containing 20 mM Tris-HCI pH 8.0, 150 mM NaCI, 1 mM NaF, 10% glycerol, 1 % NP-40, 1 mM Na3VO4, 100 KIU/ml aprotinin, 20 cg/ml PMSF, 10 cg/ml leupeptin, 5 ,ug/ml pepstatin, 10 mg/ml PNPP. The lysates were centrifuged at 14,000 x g for 20 min at 4°C. The supernatant was incubated with anti-IRS-1 antibody (10 pl), anti-IRS-2 antibody (10 pl), anti-IGF-I receptor 13-subunit antibody (1 /2g) or anti-Shc antibody (10 tcg) for 12 h at 4°C; 40 p1 of protein A-Sepharose [50% (v/v); Pharmacia Biotech, Sweden] was then added and incubation was continued for 2 h. Under 4°C, the immunoprecipitates were collected by centrifugation, washed three times with washing buffer containing 20 mM Tris-HCI, pH 8.0, 150 mM NaCI, l mM NaF, 10% glycerol, 0.1% NP-40 and boiled for 5 min in a mixture of 60 tcl of immunoprecipitation buffer and 30 ,ccl of 3 x Laemmli's sample buffer (9% SDS, 15% glycerol, 30 mM Tris-HC1, pH 7.8, 0.05% bromophenolblue, 6% 2-mercaptoethanol). These samples were then stored at -80°C until electrophoresis. A fraction of each sample that contained the same amount of proteins was subjected to immunoblotting using anti-phosphotyrosine antibody as described above.
Results
IGF 1 Promotes Both Proliferation and Di , fferentiation of SH SYSY Cells
To investigate the effects of IGF-I on SH-SY5Y cell proliferation, we measured [3H]thymidine incorporation into DNA after IGF-I treatment for 24 h and cell number after 1 to 4 days of IGF-I exposure. As These experiments were performed at least three times independently, and a representative result is presented.
(b) The cells were treated with or without IGF-I (100 ng/ml) for the indicated days and cell number was measured as described in Materials and Methods.
These experiments were performed at least three times independently, and a representative result is presented.
(c) The cells were treated with or without IGF-I at the indicated concentrations for 4 days and Northern blotting analysis was performed using 32P-labeled NPY and G3PDH cDNAs. The results of Northern blot hybridization analyses shown in the upper panel were determined quantitatively using a Fujix Bas 2000 system. The amount of NPY mRNA corrected for the amount of G3PDH mRNA is expressed as a percentage of the value of cells treated with 100 ng/ml IGF-I. These experiments were performed three times independently and a representative blot is presented.
(d) Quiescent SH-SY5Y cells were treated with various concentrations of IGF-I and neurite outgrowth was evaluated as described in Materials and Methods. These experiments were performed at least three times independently, and a representative result is presented.
shown in Figs. la and lb, IGF-I promoted DNA synthesis as well as cell proliferation. In addition, to assess differentiation, we determined mRNA levels of NPY after 4 days incubation of IGF-I and neurite outgrowth after 24 h of IGF-I treatment. IGF-I induced the expression of NPY gene and neurite outgrowth in a concentration-dependent manner (Figs.  lc, ld) . To examine whether IGF-I induced both cell growth and differentiation in the same cells, cells were incubated with or without IGF-I (100 ng/ml) for 4 days and then both BrdU incorporation and neurite outgrowth were assessed. Compared with control cells, IGF-I stimulated BrdU incorporation in cells that exhibited neurites (Figs. 2a, 2b) . These results clearly showed that a part of SH-SY5Y cells were induced to proliferate and differentiate simultaneously by IGF-I.
IGF-I Induces Tyrosine Phosphorylation of IGF-I Receptor, IRSs and Shc, Resulting in Activation of Erk and Akt Phosphorylation in SH-SY5Y Cells
We first assessed tyrosine phosphorylation of intracellular proteins in response to IGF-I.
IGF-I increased tyrosine phosphorylation of intracellular proteins that migrated with apparent molecular masses of 175-185 kDa, 120-125 kDa and 90-100 kDa (Fig. 3a) . Using immunoprecipitation with specific antibodies followed by immunoblotting with an anti-phosphotyrosine antibody, we found timedependent and IGF-I-dependent increases in tyrosine phosphorylation of the IGF-I receptor (3-subunit, IRS-1, IRS-2, and Shc (Fig. 3b) . Although phosphorylated IRS-2 was dephosphorylated rapidly, the changes in IGF-I receptor autophosphorylation correlated well with the changes in tyrosine phosphorylation of 175-185 kDa proteins (Fig. 3a) , which likely include IRS-1, as well as 66 kDa and 52 kDa Shc isoforms (Fig. 3b) . As reported by others [18, 19, 26] , IGF-I-induced activation of Erks was detected after 2 min by immunoblotting using an antibody against phosphorylated Erk (Fig. 3c) . Activation of Akt, a downstream component of PI 3-kinase, in response to IGF-I also was observed after 2 min treatment, using an anti-phospho-Akt antibody (Fig.  3c) . These results suggest that IGF-I activates sig- with 100 ng/ml IGF-I (b) for 4 days and BrdU was added at 1 h before the termination of 4 days incubation without or with IGF-I. BrdU assay was performed using In Situ Cell Proliferation Kit, AP according to manufacturer's protocol. The cultures were then photographed under a phase-contrast microscope. These experiments were performed three times independently and a representative photograph is presented. Lower panels show the higher power view (x 2) of the sites of dotted square in the upper panels. The arrows indicate the cells exhibiting neurite outgrowth, were stained by BrdU. naling proteins in both the MAP kinase and PI 3-kinase pathways.
Because we utilized PD98059 (an MEK inhibitor) and LY294002 (a PI 3-kinase inhibitor) to elucidate the importance of each signaling pathway for induction of cell growth and differentiation, we firstly examined the effects of the inhibitors on activation of Erk or Akt in response to IGF-I. Addition of 100 iM PD98059 at the stimulation of IGF-I inhibited activation of Erk, but 5 pM LY294002 did not affect IGF-I-dependent activation of Erk (data not shown). On the other hand, addition of 100 iM PD98059 at the stimulation of IGF-I had no effects on IGF-I dependent Akt activation, whereas 5 pM LY294002 inhibited Akt activation (data not shown). These results indicated that PD98059 or LY294002 specifically inhibited the MAP kinase pathway or PI 3-kinase pathway activated by IGF-I, respectively.
Blocking Either the MAP Kinase or PI 3-Kinase Pathway Completely Inhibits IGF I induced Proliferation in SH SY5Y Cells
To investigate whether the activation of the MAP kinase or PI 3-kinase pathway is required for IGF-I-induced proliferation, cells were incubated with IGF-I in the presence of PD98059 or LY294002. Each of these agents inhibited both basal and IGF-Istimulated [3H]thymidine incorporation into DNA (Figs. 4a, 4b) . After IGF-I treatment for 3 days in the absence or presence of PD98059 or LY294002, each agent also inhibited IGF-I-stimulated cell proliferation (Fig. 4c) . These results suggest that activation of both MAP kinase and PI 3-kinase pathways is essential for IGF-I-induced SH-SY5Y cell growth.
Blocking the MAP Kinase Pathway or PI3-Kinase Pathway Only Partially Inhibits IGF I induced DifJeren tiation in SH S Y5 Y Cells
We then analyzed the effects of each inhibitor on IGF-I-induced cell differentiation, as judged by NPY mRNA expression and neurite outgrowth. PD98059 only inhibited NPY expression minimally even at high concentrations (Fig. 5a ). LY294002 partially inhibited NPY expression, but concentrations higher than those required to inhibit DNA synthesis, were required (Fig. 6a) . PD98059 also had only a minimal or LY294002 (5 pM) for 30 min and incubated with IGF-I (100 ng/ml) for 3 days. Cell number was then evaluated as described in Materials and Methods.
Values are expressed as a relative increase compared to the cell number of day 0. These experiments were performed at least three times independently, and a representative result is presented. SH-SY5Y cells were pretreated without or with PD98059 at the indicated concentrations for 30 min and incubated with or without 100 ng/ml IGF-I. Northern blotting analysis after 4 days of incubation with 100 ng/ml IGF-I using 32P-labeled NPY and G3PDH cDNAs, was performed as described in Materials and Methods. The amount of NPY mRNA is expressed as described in Fig. lc . These experiments were performed three times independently and a representative blot is presented.
(b) Quiescent SH-SY5Y cells were pretreated without or with PD98059 at the indicated concentrations for 30 min and incubated with or without 100 ng/ml IGF-I. Analysis of neurite outgrowth after 24 h of incubation with 100 ng/ml IGF-I was performed as described in Materials and Methods. These experiments were performed at least three times independently, and a representative result is presented. effect on IGF-I-induced neurite outgrowth (Fig. 5b) , while LY294002 partially decreased IGF-I-dependent neurite outgrowth (Fig. 6b) . These results suggest that inhibition of the MAP kinase or PI 3-kinase pathway is not sufficient to abolish IGF-I-dependent neuronal differentiation of SH-SY5Y cells.
Blocking Both the MAP Kinase and PI 3-Kinase Pathways Completely Inhibits IGF I induced Djfjerentiation in SH SY5Y Cells
To investigate whether activation of components of either the MAP kinase or PI 3-kinase pathway is required for IGF-I-induced neuronal differentiation, IGF-I actions were studied in the presence of both PD98059 and LY294002.
Together these agents completely inhibited the expression of NPY gene (Fig. 7) and the neurite outgrowth induced by IGF-I (Fig. 8) . These results suggested that activation of some components of either the MAP kinase or PI 3-kinase pathway is sufficient for IGF-I-dependent differentiation.
Discussion
The data presented here suggest that different components of classically described IGF-I signaling pathways have a role in determining cell growth or differentiation. Furthermore, we demonstrated that IGF-I promotes cell growth and differentiation simultaneously in SH-SY5Y cells.
We have shown that known IGF-I signaling pathways are intact in these cells, that is IGF-I stimulates type I IGF receptor tyrosine kinase, followed by phosphorylation of receptor kinase substrates, such as IRS-1, IRS-2, and Shc. In addition, we observed rapid IRS-2 dephosphorylation within 10 min after IGF-I treatment.
In contrast, tyrosine phosphorylation of IRS-1 and Shc remained for at least 60 min after IGF-I stimulation.
These results suggest that tyrosine phosphorylation of these substrates are regulated in different manners.
In L6 myotubes, IRS-2 dephosphorylation was observed to be more rapid than that of IRS-1 in response to insulin [20] . Our results are discrepant with those of Kim et al. who could not demonstrate IRS-1 expression in SH-SY5Y cells [26] . The reasons for this difference are Effects of LY294002 on the expression of NPY and neurite outgrowth induced by IGF-I in SH-SY5Y cells. (a) Quiescent SH-SY5Y cells were pretreated without or with LY294002 at the indicated concentrations for 30 min and incubated with or without 100 ng/ml IGF-I. Northern blotting analysis after 4 days of incubation with 100 ng/ml IGF-I using 3'P-labeled NPY and G3PDH cDNAs, was performed as described in Materials and Methods. The amount of NPY mRNA is expressed as described in Fig. lc . These experiments were performed three times independently and a representative blot is presented.
(b) Quiescent SH-SY5Y cells were pretreated without or with LY294002 at the indicated concentrations for 30 min and incubated with or without 100 ng/ml IGF-I. Analysis of neurite outgrowth after 24 h of incubation with 100 ng/ml IGF-I was performed as described in Materials and Methods. These experiments were performed at least three times independently, and a representative result is presented.
unclear.
It is possible that the pattern of gene expression in these cells was changed during passage. Also culture conditions and experimental media utilized by Kim et al. differed from original conditions and ours [18] . As reported by others [18, 19, 26] , IGF-I stimulates Erk and Akt, and these changes in activities correlate temporally with changes of tyrosine phosphorylation of IRS-1 and Shc, and imply that IRS-1 and Shc may play more important roles in IGF-I signal transduction than IRS-2.
Another difference between our study and that of Kim et al, is [18] . They found that the MEK inhibitor PD98059 inhibited IGF-I-induced neurite outgrowth and the expression of GAP-43 neuronal marker gene. They also found that LY294002 inhibited neuronal differentiation in response to IGF-I, and that this was associated with a decrease in IRS-2 tyrosine phosphorylation [26] . We have no explanation for these differences.
In the case of PC12 cells, Traverse et al. reported that sustained activation of MAP kinase by NGF is necessary to induce differentiation [27] . In contrast, wortmannin inhibited NGF-induced neurite outgrowth in PC12 cells [29, 30] . While the MAP kinase and PI 3-kinase pathways may act independently in PC12 cells to induce neuronal differentiation, our results suggest that activation of either MAP kinase or PI 3-kinase is necessary in SH-SY5Y cells. In other words, these results suggest that in the case of IGF-I-induced neuronal differentiation, activation of some components of one pathway along the MAP kinase and PI 3-kinase pathways could compensate for those of another pathway.
Taken together, these findings would indicate cross-talk among signaling pathways.
In a number of cell types, IGF-I can induce both cell proliferation and differentiation, but apparently by distinct pathways. For example, IGF-I promotes differentiation and mitosis in fetal rat brown adipocytes and L6A1 myoblasts [31, 32] . In these cells, IGF-I-dependent MAP kinase activation plays a primary role in proliferation, while an inhibition of IGF-I-dependent MAP kinase activation by PD98059 leads to an enhancement of differentiation. At the same time, however, IGF-I stimulation of PI 3-kinase activation results in differentiation, indicating that IGF-I activates different signaling pathways to induce proliferation or differentiation. SH-SY5Y cells, therefore, seem unique in that IGF-I-dependent activation of both the MAP kinase and PI 3-kinase pathways is important for both cell proliferation and neuronal differentiation.
We need to further elucidate at which stages of induction of differentiation activation of the MAP kinase or PI 3-kinase pathway is required, and into which target molecules these two signaling pathways converge in the process of inducing cell growth.
Furthermore, our results demonstrate that IGF-I promotes proliferation and differentiation simultaneously in SH-SY5Y cells (Fig. 2) . In general, nerve cells do not proliferate after neuronal differentiation. However, there appears to be exceptions.
For example, in immature neurons from chick lumbosacral sympathetic ganglia, IGF-I induces DNA synthesis and neurite outgrowth at the same time [33] . It is possible that some nerve cells, which possess the capacity to proliferate in response to growth factors, such as neuroblastoma cells, can differentiate at least to some degree at the same time.
How do the nerve cells determine their fate in response to IGF-I, that is, whether to proceed to proliferation or differentiation? In SH-SY5Y cells, both TPA and bFGF are reported to potentiate cell differentiation induced by . In fact, we found that treatment with TPA or bFGF potentiated These experiments were performed at least three times independently and a representative result is presented.
IGF-I-induced expression of NPY and neurite outgrowth in this cell (data not shown). These results indicate that signals in the PKC or FGF pathway converge with IGF-I signaling pathways. During in vivo neuronal development, it appears that a variety of extracellular signaling molecules, including IGF, interact at specific stages [1] , and these events are likely essential for normal growth and development of the nerve system. Our findings that IGF-I can promote cell proliferation and differentiation using two distinct signaling pathways suggest that cell fate (proliferation or differentiation) and the magnitude of IGF-I activity is determined by how signaling of other factors modulates IGF-I signals of the MAP kinase and/or PI 3-kinase pathways. Clearly it is important to learn more about the mechanisms by which growth factor signals converge.
In summary, these data suggest that in SH-SY5Y cells: 1) both the MAP kinase and PI 3-kinase pathways appear essential for IGF-I-induced cell proliferation, and 2) activation of either the MAP kinase pathway and PI-3 kinase pathway is sufficient for IGF-I-dependent differentiation. Interaction between these classically described IGF-I signaling pathways and other growth factors' signaling pathways possibly play important roles in determining cell growth or neuronal differentiation.
